Leap Investments’s Chemours CC Stock Holding History

Leap Investments’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,500	Closed	-$335K	–	382
2019 Q4	$335K	Sell	18,500 -14,694	-44%	-$244K	0.16%	220
2019 Q3	$496K	Buy	+33,194	New	+$540K	0.25%	140

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Leap Investments's CC Position: Q1 2020 in Review

Leap Investments sold out of Chemours (CC) in Q1 2020, closing a stake of 18,500 shares — an estimated $335K sold.

Leap Investments first reported a position in CC in Q3 2019 and held it in 2 quarters. The position peaked at $496K in Q3 2019. 417 funds tracked by Wall St. Rank hold CC as of Q1 2020.

Leap Investments reported no remaining Chemours position as of Q1 2020 after selling out during the quarter.
Leap Investments sold 18,500 Chemours shares in Q1 2020, an estimated $335K.
Leap Investments first reported a position in Chemours in Q3 2019 and held it in 2 quarters.
Leap Investments's Chemours position peaked at $496K in Q3 2019.
417 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.